V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212702 | 20079285 | 1.7 | 89 | Palliative (P) | 2016-12-01 | 2016-12-01 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101044592 |
| 20212703 | 20079286 | 1.53 | null | Curative (C) | 2017-01-22 | 2017-01-23 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100117625 |
| 20212704 | 20079287 | 0 | 0 | Adjuvant (A) | 2017-07-10 | 2017-07-16 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101818793 |
| 20212705 | 20079288 | 1.7 | 76 | Neo-adjuvant (N) | 2019-05-19 | 2019-06-15 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100202387 |
| 20212706 | 20079289 | 1.54 | 82.7 | null | 2019-04-12 | 2019-04-12 | Capecitabine (21days) + Carboplatin | N | null | TRIAL UNSPECIFIED | 100969766 |
| 20212707 | 20079290 | 1.56 | 58.9 | Palliative (P) | null | 2017-08-09 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100141966 |
| 20212708 | 20079291 | 0 | 0 | Curative (C) | 2017-04-13 | 2017-05-07 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101596928 |
| 20212709 | 20079292 | null | 83 | Palliative (P) | 2019-03-19 | 2019-04-17 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101260136 |
| 20212710 | 20079293 | 0 | 0 | Palliative (P) | null | 2019-04-21 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101718360 |
| 20212711 | 20079294 | 0 | 0 | Neo-adjuvant (N) | null | 2020-03-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100672235 |
| 20212712 | 20079295 | 1.68 | 85.6 | Curative (C) | 2016-07-09 | 2016-07-24 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100832774 |
| 20212713 | 20079296 | 1.6 | 77 | 03 | 2019-05-24 | 2019-05-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101031498 |
| 20212715 | 20079297 | 1.73 | 63.64 | Neo-adjuvant (N) | 2019-08-18 | 2019-09-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100334470 |
| 20212716 | 20079298 | 0 | 0 | Palliative (P) | 2019-12-14 | 2020-01-09 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100126285 |
| 20212717 | 20079299 | 1.78 | 65.9 | null | 2019-11-28 | 2019-12-06 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100166189 |
| 20212718 | 20079300 | 1.65 | 77.6 | Palliative (P) | 2019-03-01 | 2019-03-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100978432 |
| 20212719 | 20079301 | 1.61 | 42.8 | Palliative (P) | 2017-06-24 | 2017-07-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101465364 |
| 20212720 | 20079302 | 1.69 | 49 | Neo-adjuvant (N) | 2018-07-06 | 2018-07-16 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100573591 |
| 20212721 | 20079303 | 1.61 | 83 | Curative (C) | 2018-12-05 | 2018-12-07 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101444951 |
| 20212722 | 20079304 | 1.55 | 50.4 | Neo-adjuvant (N) | 2018-11-03 | 2018-11-03 | CAPECITABINE + CARBOPLATIN | N | N | TRIAL UNSPECIFIED | 100814811 |
| 20212723 | 20079305 | 1.77 | 60.8 | Palliative (P) | 2017-06-01 | 2017-06-12 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101208151 |
| 20212724 | 20079306 | 1.68 | 52.7 | null | null | 2018-01-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101311161 |
| 20212725 | 20079307 | 1.74 | 57 | 03 | 2019-04-01 | 2019-04-01 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 100708621 |
| 20212726 | 20079308 | 1.71 | 67.55 | 03 | 2017-10-31 | 2017-11-29 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101500952 |
| 20212727 | 20079309 | 1.67 | 65.2 | Neo-adjuvant (N) | 2016-12-09 | 2016-12-23 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100719952 |
| 20212728 | 20079310 | 1.61 | 83 | Neo-adjuvant (N) | 2021-02-07 | 2021-02-16 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100299300 |
| 20212730 | 20079311 | 1.75 | 20 | null | 2017-03-16 | 2017-04-01 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101624818 |
| 20212731 | 20079312 | 1.61 | 88 | Palliative (P) | 2021-04-24 | 2021-04-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100148153 |
| 20212732 | 20079313 | 1.71 | 58.4 | Neo-adjuvant (N) | 2019-01-14 | 2019-01-18 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100610852 |
| 20212733 | 20079314 | 1.75 | 58 | Curative (C) | 2018-03-26 | 2018-03-26 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100647613 |
| 20212734 | 20079315 | 1.76 | 64.5 | Curative (C) | null | 2019-08-08 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100280656 |
| 20212735 | 20079316 | 1.67 | 68.3 | null | 2017-12-15 | 2017-12-29 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100446723 |
| 20212736 | 20079317 | 1.77 | 99.5 | Palliative (P) | 2016-07-01 | 2016-07-01 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101708385 |
| 20212737 | 20079318 | null | 65.7 | Curative (C) | 2016-03-09 | 2016-03-29 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | CISPLATIN + FLUOROURACIL | 100832078 |
| 20212739 | 20079319 | null | null | null | 2019-12-18 | 2019-12-31 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100277621 |
| 20212740 | 20079320 | 1.7 | 50 | Neo-adjuvant (N) | 2017-09-14 | 2017-11-02 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101242138 |
| 20212741 | 20079321 | 1.71 | 82.7 | Palliative (P) | 2017-11-28 | 2018-01-07 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101483818 |
| 20212742 | 20079322 | 1.61 | 60 | Curative (C) | 2021-07-19 | 2021-08-03 | Cisplatin +Fluorouracil (2 wk) | N | N | CISPLATIN + FLUOROURACIL | 100452669 |
| 20212746 | 20079323 | 1.63 | 69 | null | 2019-12-13 | 2019-12-25 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100304673 |
| 20212748 | 20079324 | 1.58 | 47.5 | Palliative (P) | 2020-03-17 | 2020-03-31 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100659591 |
| 20212749 | 20079325 | null | 79 | Curative (C) | 2020-01-16 | 2020-02-11 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100610409 |
| 20212750 | 20079326 | 1.67 | 90.7 | Curative (C) | 2018-03-16 | 2018-03-31 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100845739 |
| 20212752 | 20079327 | 1.73 | 101 | Palliative (P) | 2016-05-10 | 2016-05-10 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100020714 |
| 20212754 | 20079328 | 1.65 | 66.6 | Palliative (P) | 2016-06-24 | 2016-07-24 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 101033304 |
| 20212755 | 20079329 | 1.55 | 66.1 | null | 2019-08-06 | 2019-08-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100846058 |
| 20212756 | 20079330 | 1.74 | 87 | Adjuvant (A) | 2017-06-19 | 2017-06-26 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100205602 |
| 20212757 | 20079331 | 1.77 | 50.8 | Palliative (P) | 2018-07-20 | 2018-07-27 | CAPECITABINE + CARBOPLATIN | null | N | CAPECITABINE + CARBOPLATIN | 101789261 |
| 20212758 | 20079332 | 1.7 | 80.75 | Palliative (P) | 2017-01-01 | 2017-02-06 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100586417 |
| 20212759 | 20079333 | 1.81 | 88.1 | 03 | 2018-04-11 | 2018-05-04 | Capecitabine + Carboplatin + RT | 02 | null | CISPLATIN + FLUOROURACIL | 100906340 |
| 20212760 | 20079334 | 1.7 | 79.5 | Palliative (P) | 2020-01-27 | 2020-01-27 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100630656 |